In a retrospective study of home infusion patients with central line–associated bloodstream
infection, use of a central venous port, cancer diagnosis, and absence of systemic
inflammatory response syndrome were associated with use of catheter salvage. Relapse
of infection was uncommon.
Key Words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Emergence of infection control surveillance in alternative health care settings.J Infus Nurs. 2010; 33: 363-370
- Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.Clin Infect Dis. 2009; 49: 1-45
Centers for Disease Control and Prevention/National Healthcare Safety Network Device Associated Module. Central line–associated bloodstream infection (CLABSI) event. Available from: http://www.cdc.gov/nhsn/pdfs/pscmanual/4psc_clabscurrent.pdf. Accessed April 1, 2013.
- A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis. 1987; 40: 373-383
- American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med. 1992; 20: 864-874
- Simulation study of confounder-selection strategies.Am J Epidemiol. 1993; 138: 923-936
- New look at the statistical model identification.IEEE Trans Automat Contr. 1974; 19: 716-723
- Modern epidemiology.3rd ed. Lippincott Williams & Wilkins, Philadelphia (PA)2008: 425-426
Article info
Footnotes
Support/Funding: This work was supported by the National Institutes of Health (grant no. K23AI102639 to C.V.), Agency for Healthcare Research and Quality (grant no. GIM 400-4239-4-555854-XXXX-2446-2192 to S.K.), and in part by the Centers for Disease Control and Prevention Epicenters Program (grant no. U54 CK000163 to Ebbing Lautenbach).
Conflicts of interest: None to report.
Identification
Copyright
© 2014 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
